ANSTO is the new production partner of OncoBeta® GmbH in Australia
Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia
Showing 21 - 29 of 29 results
OPAL reactor back online after planned long shutdown
ANSTO’s OPAL multi-purpose research reactor at Lucas Heights has officially returned to power and recommenced operations, following a months-long planned shutdown to carry out essential maintenance and upgrades.
ANSTO to undertake routine shipment of spent fuel in 2025
Capabilities
ANSTO provides access to specialised facilities and capabilities by application. Please ensure that you contact the relevant ANSTO scientist for advice before submitting a proposal.
Statement of Intent
In January 2026, Mr Michael Quigley AM, ANSTO Board Chair, shared ANSTO's Statement of Intent with the Minister for Industry and Innovation, and Minister for Science.
Nuclear science informing risk assessments during offshore decommissioning
Environmental scientists at ANSTO have been undertaking research to gain a better understanding of the potential impact of contaminants on decommissioned offshore oil and gas infrastructure since 2017
Progress on dark matter lab
Moving earth in the search for dark matter: laboratory construction underway at mine site.
ANSTO shares award
Paper on redefinition of the kilogram receives international award
Principal Research Scientist